Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
Mask Attack Leaves Actor Blind; Diabetes Risk in Night Owls; U.S. Blood Shortage Health news and commentary from around the Web gathered by MedPage Today staff Sep 12, 2023
When Temps Rise, So Do Medical Risks. Should Docs and Nurses Talk More About Heat? "This is not your grandmother's heat," says policy expert Sep 10, 2023
New Weight-Loss Drugs Spark Debate About Safety During Surgery Some anesthesiologists think current guidelines don't go far enough Sep 08, 2023
Low-Dose Semaglutide Can Ease Insulin Need in Early T1D, Small Series Shows All 10 patients were able to eliminate prandial insulin use within 3 months Sep 06, 2023
Case Grows for SGLT2 Inhibitors as Gout Treatment Large cohort study shows expansive benefits Aug 28, 2023
SGLT2 Inhibitors, Rapid Titration, IV Iron Get a Boost in New European HF Guideline Other recommendations also released for endocarditis, cardiomyopathies, ACS, and more Aug 25, 2023
Should People Without Diabetes Use Glucose Monitors? Trend boosted by health buffs on social media, but benefit for healthy adults is unclear Aug 01, 2023
Kombucha Shows Potential Diabetes Benefit in Small Trial Diabetes patients saw glucose levels drop after drinking fermented tea Aug 01, 2023
Albuminuria Testing Falling Short in Patients at Risk for CKD If testing rates followed recommendations, some could start necessary meds sooner Jul 27, 2023
Aspartame Is a 'Possible' Carcinogen, WHO Declares But the organization's recommended limits on aspartame consumption remain unchanged Jul 13, 2023
Diabetes Projected to Affect 1.3 Billion People by 2050 Advance of disease driven by high BMI, with social determinants of health playing a role Jun 28, 2023
Protocol Optimizing Meds for T2D and CVD Pushed Beyond Cardiology Alone Endocrinologists urged to pay attention to COORDINATE trial Jun 27, 2023
Semaglutide Plus Cagrilintide Reduced Blood Sugar, Weight in T2D Once-weekly CagriSema reduced body weight more than either agent alone Jun 27, 2023
High-Dose Semaglutide Pill Just as Effective as Wegovy for Weight Loss Another study showed two high doses were better at reducing HbA1c vs a 14-mg dose Jun 27, 2023
Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trial Plus, two other studies on retatrutide show benefit in type 2 diabetes, fatty liver disease Jun 26, 2023
Bempedoic Acid Gets 'Huge' Win for Primary Prevention in the Statin-Intolerant More positive results in CLEAR Outcomes sub-analysis Jun 26, 2023
Once-Weekly Insulin Icodec Bests Daily Insulin Options for Type 2 Diabetes Superior to once-a-day insulin glargine U100 and degludec Jun 25, 2023
Near 15% Weight Loss With Novel Oral GLP-1 RA in Phase II Obesity Trial Daily orforglipron also lowered HbA1c in type 2 diabetes Jun 24, 2023
Novel Agent Leads to Fibrosis Improvement in NASH Phase IIb ENLIVEN trial saw success with various doses of pegozafermin Jun 24, 2023
Expunge Nazi-Era Medical Terms? Off-Brand Wegovy Clinics Sued; Copy and Paste Bloat Health news and commentary from around the Web gathered by MedPage Today staff Jun 21, 2023
Wide Variation in CGM Settings for Kids With Diabetes Signals Education Gaps Researcher warns of "alarm fatigue" if thresholds aren't optimized to patient Jun 20, 2023
More Evidence Backs Gout Benefit for Gliflozin Agents New study finds marked risk reduction tied to drugs' urate-lowering effect Jun 02, 2023
FDA Warns on Certain Forms of Compounded Semaglutide Some products may not contain the same active ingredient as the approved drugs Jun 01, 2023
Sotagliflozin Gets FDA's Blessing for Heart Failure SGLT1/SGLT2 inhibitor approved on the basis of SOLOIST-WHF, SCORED trials May 27, 2023
Topical Esmolol Gel Helped Heal Diabetic Foot Ulcers Significantly better than standard of care at 12 and 24 weeks May 15, 2023
Senators Call Out PBMs, Drugmakers for High Prescription Drug Costs This "is a moral issue," Sen. Bernie Sanders said during the hearing May 11, 2023
Adding This New Criteria Drastically Cut 72-Hour Insulinoma Fast Time Beta-hydroxybutyrate-based stopping point reduced burden on patients May 08, 2023
GLP-1 Agonists Come Out on Top in Cardiovascular Comparison of Newer Diabetes Meds Serious limitations noted of attempt to compare GLP-1 agonists, SGLT-2 inhibitors, however May 08, 2023
GLP-1 RAs Safe Months After Kidney Transplant Helped diabetics cut down on daily insulin dose, body weight May 08, 2023
Vascular Complications Big Contributor to Diabetes Deaths Diabetic nephropathy was most common of the fatal complications, study showed May 05, 2023
'Relaxed' A1c OK for Mitigating Dementia Risk in Older Diabetes Patients Keeping most readings under 9% avoided elevated dementia risk Apr 17, 2023
Common Diuretic Pauses Atherosclerosis in CKD, T2D If finerenone isn't available, try spironolactone, said researcher Apr 15, 2023
Certain Painkillers Linked to Heart Failure in Type 2 Diabetes Population-based study shows older patients with poorly controlled diabetes at particular risk Apr 10, 2023
Reversing Prediabetes Alone Doesn't Cut Mortality Risk Reduced risk only seen in physically active patients, Taiwanese study found Mar 28, 2023
Fresh Produce Is an Increasingly Popular Prescription for Chronically Ill Patients But do these initiatives work? Mar 26, 2023
Why Does Insulin Cost So Much? Big Pharma Isn't the Only Player Driving Prices Casting a light on profiteering methods of price mediators Mar 12, 2023
Are High Costs of Newer Diabetes Drugs Deterring Eligible Patients? Data show most eligible patients are not using GLP-1 receptor agonists or SGLT2 inhibitors Feb 27, 2023
Zero-Cal Sweetener Erythritol Disappoints on Cardiovascular Safety Keto-friendly food additive carries unknown long-term health effects Feb 27, 2023
Old Drug May Help Protect People With Diabetes Against Dementia Those with history of ischemic heart disease or stroke saw greatest protection with pioglitazone Feb 15, 2023
